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ABSTRACT
With continuous glucose monitoring (CGM), data-driven models
on blood glucose prediction have been shown to be effective in re-
lated work. However, such (CGM) systems are not always available,
e.g., for a patient at home. In this work, we conduct a study on 9
patients and examine the predictability of data-driven (aka. machine
learning) based models on patient-level blood glucose prediction;
with measurements are taken only periodically (i.e., after several
hours). To this end, we propose several post-prediction methods to
account for the noise nature of these data, that marginally improves
the performance of the end system.
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1 INTRODUCTION
Diabetes mellitus has been a major and global problem for a long
time, as it is report that there are over 400 million patients over the
world 1. The knowledge of glucose concentration in blood is a key
aspect in the diagnosis and treatment of diabetes. The use of signal
processing techniques on glucose data started a long time ago, when
glucose time-series in a given individual could be obtained in lab
study from samples drawn in the blood at a sufficiently high rate.
In particular, related work employed not only linear (e.g., correla-
tion and spectrum analysis, peak detection), but also nonlinear (e.g.,
approximate entropy) methods to investigate oscillations present in
glucose (and insulin) time-series obtained, during hospital monitor-
ing, by drawing blood samples every 10-15 min for up to 48 h [8].
In these settings, long term (e.g., days or months) studies resorted to
self-monitoring blood glucose (SMBG) data, i.e., approx. 3 samples
per day obtained by the patient herself by using fingerstick glucose
meters. The retrospective analysis of SMBG time-series was used
by physicians, together with the information taken from the ‘pa-
tient’s diary‘ (e.g., insulin dosage, meals intake, physical exercise)
and some glycaemic indexes (typically HbA1c), to assess glucose
control and the effectiveness of a particular therapy [8].
With the support of continuous glucose monitoring (CGM) sen-
sors, the development of new strategies for the treatment of diabetes
has been accelerated in recent years. In particular, CGM sensors
can be injected into ‘online‘ recommender systems that are able to
generate alerts when glucose concentration is predicted to exceed the
normal range thresholds. Recently, there has been a lot of complex
1https://www.diabetes.co.uk/diabetes-prevalence.html
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data-driven prediction models [3–5, 7] that are built based on the
CGM data, and have been shown to be effective. These data-driven
models, or machine learning/deep learning are data-hungry, hence,
its performance on sparse / non-continuous data is still a question.
CGM data are still not always available for all diabetic patients for
many reasons 2; while a personalized or patient-level model that are
trained on the same patient’s data is essential. In this work, we exam-
ine the performance of these machine leaning approaches on our real,
limited data of a group of diabetic patients. Our contributions are
two-fold: (1) we provide a quantitative study on the predictability of
machine learned models on limited and sparse data; (2) we propose
a prediction system that is robust on noisy data (based on prediction
interval).
2 DATASET OVERVIEW
The data collection study was conducted from end of February to
beginning of April 2017 and includes 9 patients who were given
specially prepared smartphones. Measurements on carbohydrate
consumption, blood glucose levels, and insulin intake were made
with the Emperras Esysta system 3. Measurements on physical ac-
tivities were obtained using the Google Fit app. We use only steps
information (number of steps) for our study.
We describe briefly here some basic patient information. Half of
the patients are female and ages range from 17 to 66, with a mean age
of 41.8 years. Body weight, according to BMI (Body mass index), is
normal for half of the patients, four are overweight and one is obese.
The mean BMI value is 26.9. Only one of the patients suffers from
diabetes type 2 and all are in ICT therapy 4. In terms of time since
being diagnosed with diabetes, patients vary from inexperienced (2
years) to very experienced (35 years), with a mean value of 13.9
years. We anonymize the patients and identify them by IDs (from 8
to 17, we do not have information for patient 9).
Frequency of Measurements
We give an overview of the number of different measurements that
are available for each patient. The study duration varies among
the patients, ranging from 18 days, for patient 8, to 33 days, for
patient 14. Likewise, the daily number of measurements taken for
carbohydrate intake, blood glucose level and insulin units vary across
the patients. The median number of carbohydrate log entries vary
between 2 per day for patient 10 and 5 per day for patient 14. Median
number of blood glucose measurements per day varies between 2
and 7. Similarly, insulin is used on average between 3 and 6 times
per day. In terms of physical activity, we measure the 10 minute
2http://time.com/4703099/continuous-glucose-monitor-blood-sugar-diabetes/
3https://www.emperra.com/en/esysta-product-system/
4describes as a model of an insulin therapy for the diabetics with two different types of
insulin.
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intervals with at least 10 steps tracked by the google fit app. This
very low threshold for now serves to measure very basic movements
and to check for validity of the data. Patients 11 and 14 are the most
active, both having a median of more than 50 active intervals per
day (corresponding to more than 8 hours of activity). Patient 10 on
the other hand has a surprisingly low median of 0 active 10 minutes
intervals per day, indicating missing values due to, for instance, not
carrying the smartphone at all times.
Measurements per Hour of Day
Figure 3 show measurements of blood glucose, carbohydrates and
insulin per hour of day for patient 13 and 14. Overall, the distribution
of all three kinds of values throughout the day roughly correspond
to each other. In particular, for most patients the number of glu-
cose measurements roughly matches or exceeds the number of rapid
insulin applications throughout the days. Notable exceptions are pa-
tients 14, 15, and 17 (figures excluded). For patient 14, in the evening
the number of meals and rapid insulin applications match but exceed
the number of blood glucose measurements by far. Patient 17 has
more rapid insulin applications than glucose measurements in the
morning and particularly in the late evening. For patient 15, rapid in-
sulin again slightly exceeds the number of glucose measurements in
the morning. Curiously, the number of glucose measurements match
the number carbohydrate entries – it is possible the discrepancy is a
result of missing (glucose and carbohydrate) measurements. We fur-
ther show the blood glucose distribution of each patient in Figure 1.
The different lengths of the interquartile range for each distribution
also reflects the difficulty of prediction problem on different patients.
Figure 1: Blood glucose distribution for each patient.
Figure 2: Blood glucose prediction scenario.
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Figure 3: Glucose, carbohydrate and insulin values per hour of
day for patients 13 and 14.
3 PREDICTION
Our first approach to blood glucose prediction is based on a re-
gression type form of time series prediction. Given historical blood
glucose data, we learn a model that predicts future glucose values
based on a representation of the current situation (including the
recent past), using information on patient context, recent insulin
applications, carbohydrate intake, and physical activity levels.
3.1 Setup
Prediction task. Our prediction task is a time series prediction
of blood glucose values (in mmol/L) with a prediction horizon of
1 hour. Consequently, we can construct a data instance for each
glucose measurement found in the dataset and use all information
available up until 1 hour before the measurement for predicting the
glucose value (c.f., Figure 2).
Evaluation Protocol. Performance is evaluated on a per patient
basis. In addition, we average performance over patients to get
an overview. For each patient, we consider the first 66% of blood
glucose measurements as training data to learn the models and the
last 34% as test data to evaluate prediction performance.
Performance Measures. Prediction performance is measured in
terms of median absolute error (MdAE), root mean squared error
(RMSE) and symmetric mean absolute percentage error (SMAPE).
Given are ground truth values yi and predictions yˆi, with i ∈ 1,n.
Median absolute error measures the median error made and is defined
as
MdAE = median
i
|yˆi− yi|.
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Root mean squared error weighs larger errors more heavily and is
defined as
RMSE =
√
n
i=1yˆi− yi2
n
.
Symmetric mean absolute percentage error relates prediction
errors to predicted values. It is defined as
SMAPE =
100%
n
n
i=1
|yˆi− yi|
|yi|+ |yˆi|2 .
Note that this gives a result between 0% and 200%. Further, the mea-
sure penalizes a) deviating for low values and b) over-forecasting.
3.2 Algorithms
Simple Baselines. As standard simple baselines, we use the last
value observed one hour before the value that is being predicted
(Last) and the arithmetic mean of glucose values in the training set.
Context-AVG. As a more advanced baseline, we use a (temporal)
context weighted average of previous glucose values. As our analysis
showed differences in glucose values according to time of the day, we
weigh previous glucose values base on temporal proximity, weighted
exponentially decreasing in the difference of time of day.
Long-short-term-memory. . LSTM is a recurrent neural network
model that effectively accounts for the long-term sequence depen-
dence among glucose inputs.
RandomForest. The Random Forest Regressor (RF) is a meta
estimator that learns an ensemble of regression trees [2], averaging
the output of individual regression trees to perform the prediction.
We use a standard value of 500 estimators, as well as a minimal
leaf size of 4 for the individual trees to reduce overfitting of the
individual models.
ExtraTrees. The Extra-Trees Regressor (ET) is a variation on Ran-
domForest that uses a different base learner: Extremely randomized
trees [6]. In contrast to regular regression trees, best split values per
feature are chosen randomly. We use 300 estimators and a minimum
leaf size of 2.
3.3 Overall Results
In this section we report aggregate results, averaged over all patients.
Table 1 shows regression performance averaged over all patients.
Performance is based on 42 test instances on average. The simple
baselines Last and AVG achieve median errors of 3.3 and 2.5 mmol/L.
Weighing previous glucose values based on time of the day (Context-
AVG) improves average median errors to 2.28 mmol/L. The Extra-
Trees Regressor achieves the lowest MdAE of 2.16 and similarly
slightly outperforms Context-AVG in terms of RMSE and SMAPE.
In comparison to predicting the arithmetic mean (AVG), however,
RMSE does not improve by much (12.15 vs 12.96), indicating that
the ensemble is not able to predict extreme errors well on average.
We additionally report the performance of a neural-network based
model, the Long-short-term-memory (LSTM), trained with 10 and
100 epochs. LSTM seems to be quite stable for MdAE but varies
substantially for RMSE and SMAPE. The performance of LSTM
actually gets much worse after 100 epochs, that indicates the prone
to overfitting. This show the instability of the model towards our
dataset, and thus we do not consider the LSTM results for model
comparison in Table 1.
Method MdAE RMSE SMAPE
Last 3.28 25.71 40.96
AVG 2.51 12.96 31.42
Context-AVG 2.28 12.53 29.71
ARIMA 2.40 13.88 31.61
LSTM (10 iter) 2.24 10.41 29.02
LSTM (100 iter) 2.76 19.24 35.64
RandomForest 2.27 12.05 29.98
Extremely (randomized) Trees 2.16 12.15 29.56
Table 1: Overall regression performance averaged over all pa-
tients. Best performance per measure is marked in bold (results
in italic are not considered for comparison).
4 PREDICTION CONFIDENCE
In this section, we study the confidence of our best performed predic-
tion tree-based models, RandomForest and ExtraTrees. This would,
to an extent, facilitate us to answer an important question, when the
system is reliable enough to give out predictions. Thus, we study
the variability of predictions and estimate standard errors for the
prediction model.
Prediction intervals. When looking at two regression models,
while the model predictions could be similar, confidence in them
would vary if we look at the training data, a less and more spread out
data could bring a low confidence. Hence, a prediction returning a
single value (typically meant to minimize the squared error) likewise
does not relay any information about the underlying distribution of
the data or the range of response values. We hence, leverage the
concept of prediction intervals to supplement for the noisy data
and enhance the end model, in the sense that it can refuse to give
prediction at certain time when the confidence is low.
A prediction interval or confidence interval is an estimate of an
interval into which the future observations will fall with a given
probability. In other words, it can quantify our confidence or cer-
tainty in the prediction. Unlike confidence intervals from classical
statistics, which are about a parameter of population (such as the
mean), prediction intervals are about individual predictions [1]. We
leverage the confidence interval estimations for Random Forests,
proposed in [9], that account for certain variability estimation (of
individual trees) bias to conduct the experiments.
4.1 Regression evaluation
We report here the variablity evaluation across all patients for the
regression task. Figure 4 show the error bars using unbiased variance
for all patients. We then show in Figures 5 the error bar graphs for
patient 8 in an incremental training size setting – meaning that we
keep the same actual test set, but training on only part of the training
data. E.g., 14 training data indicates that we ‘look back’ on only 14
of the available past data. The more dots that near the diagonal show
the more ‘accurate’ is our prediction model. And the error bars show
the ‘confidence’ interval. Figure 5(a) indicates the high ‘confidence’
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in the predictions with little training data, yet the dots are far away
from the diagonal.
(a) Patient 8 (b) Patient 10 (c) Patient 11
(d) Patient 12 (e) Patient 13 (f) Patient 14
(g) Patient 15 (h) Patient 16 (i) Patient 17
Figure 4: Error bar graphs for predicted BG using unbiased
variance.
(a) 1/4 training data (b) 2/4 training data
(c) 3/4 training data (d) 4/4 training data
Figure 5: Incremental training size - error bar graphs for pre-
dicted BG using unbiased variance for patient 8.
4.1.1 when to predict: on the training size evaluation. To answer
this question, we set up an evaluation setting with increasing size of
number of instances, order by time. Each training point is evaluated
by leave-one-out validation. We show in Figure 6 the results for
patient 8. The general conclusion is the that the more training data,
the better the performance is, as witness for patient 13, 15 or 17.
However, the results for such patients e.,g patient 8, 11 or 16 show
that the training size increment could also bring more noise and
decrease the results. We envision that it could because the learned
model is not stabilized yet with the limited number of instances in
our experiment. In addition, training size is not the only factor to
decide when to predict. We hence move on to examine the other
two factors: (1) model stability - via std. dev. and (2) prediction
confidence toward coming instances.
4.1.2 when to predict: on the model stability. To answer this
question, we measure the stability of the model by the standard
deviation of the k-fold cross validation with incremental training
size. Figure 10 indicate on MAE and RMSE metrics, the model
seems to be more stabilized with the more number of training data.
This is a good indicator for the when to predict questions.
4.1.3 when to predict: on the prediction confidence. We show in
Figure 8 and Figure 9 the confidence distribution at each run of the 5-
fold CV for different patients based on bias and no-bias confidences
respectively. The results show the confidence distributions are rather
similar across different run, indicating that the temporal order of the
instances does not impact much on the model performance. Base
on the distribution, we move on the the threshold parameter tuning
for the data filtering using confidence interval. The idea is to answer
the question, "if we filter low confidence instances (high confident
interval), will the model perform better?"
The answer somehow is depicted in Figure 11. For some patients
i.e., patient 10, 13, the filtering technique substantially enhance the
model performances on MAE and RMSE (not shown) metrics. It is
witness that the biased confidence measure somewhat works better
than non-biased one across patients. However, for some patients i.e.,
patient 8 it seems does not bring any effects.
We move on to experiment with filtering instances that we em-
pirically witness that it seems lacking of preditable context within
the training data. They are the BG measurements at night. We then
attempt to filter those out for prediction. Even though slightly im-
proving for some (c.f., Figure 12), overall the filtering attempt does
not make significant difference, indicating that our model learns it
better than we expect.
4.1.4 when to predict: combined factors. Figure 7 show some
highlighted combined filtering techniques. In general, combining
the aforementioned factors together does improve the model per-
formance. However, the combination is not straightforward, e.g.,
confidence interval filtering lower the performance at the starting
time when the model is unstable aka. cold start. Hence, there is not
enough evidence for us to make a hard decision. The more trial-and-
error attempts on the fly or a bigger dataset however will be at ease
to be built on these as a foundation.
4.2 Overall results with Filtering methods
We show in Table 2 the overall results of our models with different
filtering approaches for all patients. We use 2 different filtering ap-
proaches: (1) Sanity filter, heuristics (e.g., remove out wrongly input
measurement or moments when the last glucose level input is too
far) that remove noise and (2) Stability filter: prediction confidence
(std. dev is not needed when the training size is large enough). The
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results show that the stability filter (based on bias and bias-corrected)
achieve the best performance, without the need of human efforts on
sanity filter. Sole stability filter also provide more predictions (avg.
24) than other filtering combination.
(a) Patient 8 (b) Patient 10 (c) Patient 11
(d) Patient 12 (e) Patient 13 (f) Patient 14
(g) Patient 15 (h) Patient 16 (i) Patient 17
Figure 6: Leave-one-out cross validation with incremental train-
ing size.
(a) Patient 8 (b) Patient 13
(c) Patient 15 (d) Patient 16
Figure 7: 5-fold cross validation with incremental training size.
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Figure 8: Confidence distributions at each run of 5-fold CV for
predicted BG using biased variance.
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Figure 9: Confidence distributions at each run of 5-fold CV for
predicted BG using unbiased variance.
(a) Patient 15 (b) Patient 17
Figure 10: Standard deviation with incremental training size.
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Table 2: Average performance of different filtering approaches
for all patients.
Model # predictions MAE MdAE RMSE SMAPE
rf 42 2.58 2.27 12.05 29.98
et 42 2.55 2.16 12.15 29.56
rf + sanity filter 16 2.22 2.01 8.80 28.10
et + sanity filter 16 2.29 2.06 9.01 29.36
rf + sanity + stability filter 15 2.22 1.92 8.71 27.82
rf + stability filter 24 1.92 1.77 7.57 22.65
5 CONCLUSION
We studied the predictability of machine-learning models in the
scenarios of non-continuous blood glucose tracking. Additionally,
we studied the stability and robustness of the learned model over
time. We show that Random Forest and Extra Tree ensemble-based
models are the most suitable models for this case, as they can account
for the outliers as well as overfitting problems when the data are
limited. Our further study on the prediction confidence show that the
model can give reliable predictions after acquiring 25-30 instances.
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